Adipose tissue as a living drug: Stromal vascular fraction and adipose tissue-derived stem cells in regenerative medicine.
Choudhery MS., Niaz A., Arif T., Mahmood R.
Narrative Review on Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- World J Stem Cells (2025)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41480399
- PMCID
- PMC12754547
- DOI
- 10.4252/wjsc.v17.i12.114170
Abstract (original English)
Adipose tissue has emerged as a rich and clinically relevant source of regenerative cells. It offers a minimally invasive, abundant, and autologous reservoir for therapeutic applications. Among its cellular components, the stromal vascular fraction (SVF) and adipose-derived stem cells (ASCs) have gained considerable attention due to their potent regenerative and immunomodulatory capacities. SVF is a heterogeneous mixture of cells, whereas ASCs constitute a more homogeneous mesenchymal stem cell-like population obtained through in vitro expansion. Together, these cell populations (SVF and ASCs) are described as "living drugs", as they are viable and act as dynamic biological agents within the body. Unlike conventional medicines, living drugs exert therapeutic effects not only through direct differentiation but also via the secretion of bioactive molecules, including cytokines, growth factors, and extracellular vesicles. These secreted factors can modulate the surrounding microenvironment, enhance tissue repair, and regulate immune responses. Such paracrine mechanisms often play a more significant role than direct cell replacement, making living drugs versatile tools for regenerative medicine. This review provides a comprehensive overview of SVF and ASCs as living drugs. It discusses their cellular composition, mechanisms of action, methods of isolation, and the regenerative biom
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol